Filing Details

Accession Number:
0001225208-10-025620
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-24 17:00:42
Reporting Period:
2010-11-24
Filing Date:
2010-11-24
Accepted Time:
2010-11-24 17:00:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1440664 D Carlyn Solomon One Edwards Way
Irvine CA 92614
Cvp, Critical Care & Vascular No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-24 22,000 $24.42 58,386 No 4 M Direct
Common Stock Acquisiton 2010-11-24 10,200 $25.81 68,586 No 4 M Direct
Common Stock Acquisiton 2010-11-24 8,250 $21.96 76,836 No 4 M Direct
Common Stock Disposition 2010-11-24 40,450 $65.90 36,386 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2010-11-24 10,200 $0.00 10,200 $25.81
Common Stock Employee Stock Option (Right to Acquire) Disposition 2010-11-24 22,000 $0.00 22,000 $24.42
Common Stock Employee Stock Option (Right to Acquire) Disposition 2010-11-24 8,250 $0.00 8,250 $21.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,400 2008-02-15 2014-02-14 No 4 M Direct
22,000 2008-05-10 2014-05-09 No 4 M Direct
0 2007-05-11 2013-05-10 No 4 M Direct
Footnotes
  1. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  2. This transaction was executed in multiple trades at prices ranging from $65.80 to $66.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.